Matches in Wikidata for { <http://www.wikidata.org/entity/Q85262243> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q85262243 description "article scientifique publié en 2014" @default.
- Q85262243 description "artículu científicu espublizáu n'agostu de 2014" @default.
- Q85262243 description "scientific article published on 21 August 2014" @default.
- Q85262243 description "wetenschappelijk artikel" @default.
- Q85262243 description "наукова стаття, опублікована в серпні 2014" @default.
- Q85262243 name "A validated liquid chromatography tandem mass spectrometry method for simultaneous determination of pioglitazone, hydroxypioglitazone, and ketopioglitazone in human plasma and its application to a clinical study" @default.
- Q85262243 name "A validated liquid chromatography tandem mass spectrometry method for simultaneous determination of pioglitazone, hydroxypioglitazone, and ketopioglitazone in human plasma and its application to a clinical study" @default.
- Q85262243 type Item @default.
- Q85262243 label "A validated liquid chromatography tandem mass spectrometry method for simultaneous determination of pioglitazone, hydroxypioglitazone, and ketopioglitazone in human plasma and its application to a clinical study" @default.
- Q85262243 label "A validated liquid chromatography tandem mass spectrometry method for simultaneous determination of pioglitazone, hydroxypioglitazone, and ketopioglitazone in human plasma and its application to a clinical study" @default.
- Q85262243 prefLabel "A validated liquid chromatography tandem mass spectrometry method for simultaneous determination of pioglitazone, hydroxypioglitazone, and ketopioglitazone in human plasma and its application to a clinical study" @default.
- Q85262243 prefLabel "A validated liquid chromatography tandem mass spectrometry method for simultaneous determination of pioglitazone, hydroxypioglitazone, and ketopioglitazone in human plasma and its application to a clinical study" @default.
- Q85262243 P1433 Q85262243-724F2CCD-EDCC-44FE-A966-A012BD9209E0 @default.
- Q85262243 P1476 Q85262243-50D72552-F0BE-4163-96DF-3946A5B376B9 @default.
- Q85262243 P2093 Q85262243-09E69176-25DA-41A8-88BC-8563213CE19A @default.
- Q85262243 P2093 Q85262243-5BBC09E7-DC6B-40F7-8BDB-780B5606A9AB @default.
- Q85262243 P2093 Q85262243-78D76789-7F91-435D-BC38-48A6101ED242 @default.
- Q85262243 P304 Q85262243-9490FAB7-49B0-46D3-8D10-377AD2278509 @default.
- Q85262243 P31 Q85262243-77A5F4CA-D283-4D6E-BF7C-EA3E67771638 @default.
- Q85262243 P356 Q85262243-8074DE41-5747-4112-88CE-C129D2B0435B @default.
- Q85262243 P478 Q85262243-A0FFC010-8525-4EDF-9C4E-B1540884C9CF @default.
- Q85262243 P50 Q85262243-B7B11A45-5B6C-4DBB-BDC1-2FD30EB747DF @default.
- Q85262243 P50 Q85262243-F770156D-4016-4C2F-A786-03756FBDB78B @default.
- Q85262243 P577 Q85262243-6ED4ADBF-C411-4599-AD3E-7253BF9ACA48 @default.
- Q85262243 P698 Q85262243-B8CF32FB-7C70-42E0-9920-6D3EBA15FBD1 @default.
- Q85262243 P921 Q85262243-1F5638A1-C68A-47BD-83AE-AD1818D7CE83 @default.
- Q85262243 P921 Q85262243-E5D453F5-23DA-4769-A32B-351C75A00DE2 @default.
- Q85262243 P356 J.JCHROMB.2014.08.019 @default.
- Q85262243 P698 25195022 @default.
- Q85262243 P1433 Q2422407 @default.
- Q85262243 P1476 "A validated liquid chromatography tandem mass spectrometry method for simultaneous determination of pioglitazone, hydroxypioglitazone, and ketopioglitazone in human plasma and its application to a clinical study" @default.
- Q85262243 P2093 "Kenneth Cusi" @default.
- Q85262243 P2093 "Marina Kawaguchi-Suzuki" @default.
- Q85262243 P2093 "Paola Portillo Sanchez" @default.
- Q85262243 P304 "219-223" @default.
- Q85262243 P31 Q13442814 @default.
- Q85262243 P356 "10.1016/J.JCHROMB.2014.08.019" @default.
- Q85262243 P478 "969" @default.
- Q85262243 P50 Q37370763 @default.
- Q85262243 P50 Q56994782 @default.
- Q85262243 P577 "2014-08-21T00:00:00Z" @default.
- Q85262243 P698 "25195022" @default.
- Q85262243 P921 Q117788892 @default.
- Q85262243 P921 Q27156475 @default.